Los Angeles & San Francisco Daily Journal
Bazaarvoice Merger Faces a Bizarre Fate After Court Ruling
March 21, 2014
What if the government told you that you have to license your intellectual property to your closest competitor, and allow your employees to work for that same competitor and disclose your trade secrets? That is the position that one company finds itself in as a result of an adverse verdict earlier this year in an antitrust case brought by the Department of Justice in federal district court in San Francisco.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents Private Equity at Goldman Sachs Alternatives in the Acquisition of FGI WorldwideMay 12, 2026When “The Devil Made Me Do It” Is Not a Defense: Lessons in AI Governance and Organizational Oversight from an SDNY DecisionMay 11, 2026Sidley Represents Siris Capital in Its US$4.2 Billion Sale of EquinitiMay 5, 2026April Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust IssuesApril 23, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
